Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: A Multicenter Study.

Jason C GallagherMichael J SatlinAbdulrahman ElaborNidhi SaraiyaErin K McCrearyEsther MolnarClaudine El-BeyroutyBruce M JonesDeepali DixitEmily L HeilKimberly C ClaeysJon HilesNikunj M VyasChristopher M BlandJin SuhKenneth BiasonDorothy McCoyMadeline A KingLynette RichardsNicole HarringtonYi GuoSaira ChaudhryXiaoning LuDaohai Yu

Published in: Open forum infectious diseases (2018)

Ceftolozane-tazobactam appeared to be effective in the treatment of multidrug-resistant P aeruginosa infections, particularly when initiated early after the onset of infection.

Keyphrases

multidrug resistant
gram negative
pseudomonas aeruginosa
acinetobacter baumannii
drug resistant
cystic fibrosis
klebsiella pneumoniae
escherichia coli
combination therapy